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MICROBIAL BIOFILMS: AN EVALUATION OF ECOLOGICAL INTERACTIONS AND
THE USE OF NATURAL PRODUCTS AS POTENTIAL THERAPEUTIC AGENTS

by

ARIEL J. SANTIAGO

Under the Direction of Eric S. Gilbert, PhD

ABSTRACT
Biofilms are communities of microorganisms associated with surfaces encased in a
protective extracellular matrix. These communities often pose clinical and industrial challenges
due to their ability to tolerate biocidal treatments and removal strategies. Understanding the
ecological interactions that take place during biofilm establishment is a key element for designing
future treatment strategies.

In this work, I utilized unique methods for studying factors

contributing to cooperative antibiotic detoxification in a polymicrobial biofilm model.
Subsequently, I tested a novel compound mixture that exhibited promising antibiofilm properties.
Escapin is an L-amino acid oxidase that acts on lysine to produce hydrogen peroxide (H2O2),

ammonia, and equilibrium mixtures of several organic acids collectively called Escapin
intermediate products (EIP). Previous work showed that the combination of synthetic EIP and
H2O2 functions synergistically as an antimicrobial toward diverse planktonic bacteria. To test the
combination of EIP and H2O2 on bacterial biofilms, Pseudomonas aeruginosa was selected as a
model, due to its role as an important opportunistic pathogen.

Specifically, I examined

concentrations of EIP and H2O2 that inhibited biofilm formation or fostered disruption of
established biofilms. High-throughput assays of biofilm formation using microtiter plates and
crystal violet staining showed a significant effect from pairing EIP and H2O2, resulting in inhibition
of biofilm formation relative to untreated controls or to EIP or H2O2 alone. Similarly, flow cell
analysis and confocal laser scanning microscopy revealed that the EIP and H2O2 combination
reduced the biomass of established biofilms relative to controls. Area layer analysis of biofilms
post-treatment indicated that disruption of biomass occurs down to the substratum.

Only

nanomolar to micromolar concentrations of EIP and H2O2 were required to impact biofilm
formation or disruption, which are significantly lower concentrations than those causing
bactericidal effects on planktonic bacteria. Micromolar concentrations of EIP and H2O2 combined
enhanced P. aeruginosa swimming motility compared to either EIP or H2O2 alone. Collectively,
these results suggest that the combination of EIP and H2O2 may affect biofilms by interfering with
bacterial attachment and destabilizing the biofilm matrix.

INDEX WORDS: Biofilms, Escherichia coli, Pseudomonas aeruginosa, escapin, hydrogen
peroxide, natural products, biofilm inhibition, biofilm dispersal
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1.1

INTRODUCTION

Biofilms: diverse and complex communities of microorganisms
The complexity of the microbial world is often oversimplified or misunderstood. This

often leads to the common misconception that microorganisms exist as pure cultures of planktonic
cells.

Microorganisms, however, are more likely to exist in surface-attached, complex

multispecies communities encased in a protective extracellular matrix (2). The composition of
this matrix varies from species to species; however, it is generally composed of lipids,
polysaccharides, nucleic acids, and proteins. The interplay between these components provides a
three-dimensional structure that holds cells together (3), maintains key enzymes in their immediate
environment (4), while providing protection from environmental threats (5).
In addition to the complexity of the biofilm structure and composition, the diversity of
environments in which biofilms exists are well documented (6). From growth in hydrothermal
vents to implanted medical devices, biofilms are able to establish and thrive in many environments.
In many cases, however, their presence leads to economic loss (7, 8) as well as increased morbidity
and mortality (9).
1.2

Antibiotic resistance: an evolutionary arms race
The discovery and development of antibiotics has undoubtedly changed the way humanity

has dealt with bacterial infections for nearly three-quarters of a century. Unfortunately, widespread
and indiscreet use of these drugs over the last 50-60 years has led to the emergence of antibiotic
resistance among previously susceptible pathogenic strains (10, 11). The emergence of multi-drug
resistant strains has led to a push for the development of alternative methods of chemotherapeutic
treatments with the goal of reducing the incidence of resistance (12, 13). While research for
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alternatives is both promising and ongoing, at present, the reliance on conventional antibiotics in
clinical settings is still high. Chronic exposure to various types of antibiotics has provided a spark
in an evolutionary “arms race” in which bacteria have developed mechanisms for the spread of
resistance genes as well as stabilization of resistant phenotypes (11).
1.3

Natural products and the emergence of anti-virulence strategies
The increase in prevalence of bacterial strains that are resistant to current antibiotic

treatments has led to the emergence of anti-virulence strategies that can overcome many of the
evolutionary-driven resistance mechanisms that currently exist (14). These strategies include
screening small molecule libraries for antimicrobial effects (15), matrix degrading enzymes (16),
antimicrobial surface coatings (17, 18), among others. In general, anti-virulence strategies aim to
disrupt mechanisms or pathways that contribute to infection and disease while minimizing the
evolutionary triggers that lead to drug-resistance (19).
Many of these biologically active compounds are naturally derived from vastly diverse
sources. For example, plant-derived compounds such as cinnamaldehyde (essential oil) have been
shown to disrupt biofilm formation in Escherichia coli and methicillin-resistant Staphylococcus
aureus (20, 21) and reduce virulence in Vibrio spp. by interfering with quorum-sensing
mechanisms (22). L-Amino acid oxidases and their enzymatic by-products, found in snake venom
(23), the epidermal mucus of marine fish (24), and defensive secretions of marine invertebrates
(25), have well-documented antimicrobial effects against both Gram-positive and Gram-negative
pathogens through various mechanisms. The identification of these biologically active compounds
and their prospective applications as chemotherapeutic agents will provide a major boost to the
armament of drugs currently available.
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1.4

Objectives and hypotheses

1.4.1 Factors affecting polymicrobial biofilm establishment
The objective of this work is to further our collective understanding of the factors affecting
the establishment of polymicrobial biofilms. In many cases, the polymicrobial nature of these
communities complicates treatment strategies and prolongs periods of disease (26). To this end,
we have incorporated methods for studying initial polymicrobial formation in order to test the
following hypotheses. 1) Colonization of a surface is key during initial biofilm formation.
Therefore it is hypothesized that polymicrobial biofilm formation by antibiotic resistant strains
could be enhanced by increasing the areal density, or the number of attached cells per microscopic
field. The areal density of a constructed biofilm can be influenced by adjusting the inoculum
density of the strains used during initial biofilm formation and thus can be used to model its overall
impact. 2) Nutrient availability during biofilm formation could promote rapid growth of bacteria
and ultimately influence biomass accumulation during biofilm formation. It is hypothesized that
this increase in biomass accumulation would result in improved antibiotic tolerance in biofilms
grown under antibiotic challenge. 3) Antibiotic exposure during early biofilm formation has been
known to trigger biofilm formation (27). Thus, it was hypothesized that antibiotic exposure during
early biofilm formation would enhance the antibiotic tolerance of strains forming biofilms under
antibiotic challenge.
1.4.2 The use of natural products as potential therapeutic agents
The use of bioactive natural products with antimicrobial properties has opened new
avenues of treatment strategies for combating antibiotic resistance. One of these natural products
known as escapin, is an L-amino acid oxidase that reacts with L-lysine to produce an equilibrium
mixture of organic acids, hydrogen peroxide, and ammonium (1). These components were found
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to exhibit antimicrobial properties against planktonic cultures of relevant bacterial pathogens (28)
and as a result, it was hypothesized that the same components would exhibit inhibitory or
dispersive effects towards bacterial biofilms. The work associated in this investigation used the
opportunistic human pathogen Pseudomonas aeruginosa as a model.
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Factors affecting early stage polymicrobial biofilm formation in the presence of
multiple antibiotics

2.1

Introduction
Microorganisms are often perceived as free-floating cells that exist as single entities in

their environment; however, they are more commonly found in structured, multispecies
communities known as biofilms (29). Biofilms are typically characterized by their attachment to
surfaces (biotic and abiotic) as well as their production of an extracellular polymeric matrix in
which the microbial community is encapsulated. This protective matrix allows microorganisms to
withstand adverse environmental conditions including biocidal treatments (30). Biofilms are
ubiquitous in nature, and their presence extends to medical, environmental, and industrial settings.
The negative impact of biofilms is of particular importance in clinical settings. Biofilm
communities, as well as their inherent resistance to antimicrobial agents, are at the root of many
persistent and chronic bacterial infections (29). For example, biofilms of the human pathogen
Pseudomonas aeruginosa are frequently responsible for chronic infections in cystic fibrosis
patients (31). Another biofilm-based issue encountered in clinical settings is device-related
infections; for example, catheter-associated infections, which are major causes of nosocomial
bloodstream infections (32). Additionally, multi-drug resistance often occurs once biofilms
mature; this problem may be compounded in polymicrobial biofilms, complicating treatment (33,
34).
An approach to managing biofilm infections is to control early stage surface colonization.
Factors that affect surface colonization by microorganisms include electrical charge (35),
hydrophobicity (36) and fimbriae (37). To date, limited work has been carried out on parameters
affecting surface colonization by more than one strain of bacterium, especially in the presence of
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multiple antibiotics as are used in combination therapies (38). In this work, we investigated factors
affecting bacterial surface colonization in the presence of multiple antibiotics. These factors
include 1) areal density, or the number of surface-attached cells during early stages of biofilm
formation; 2) availability of nutrients during early attachment and its ultimate impact on biomass
accumulation in the presence of antibiotics; and 3) how antibiotic exposure during initial biofilm
formation impacts overall biofilm development in the presence of antibiotics. The work expands
on a previously established method of constructing multi-species biofilms (39) and research on the
role of antibiotic resistance mechanisms and biofilm structure on biofilm formation by antibioticsensitive and -resistant strains (40).
2.2

Materials and Methods

2.2.1 Strains and culture conditions
Strains were graciously provided by H.A. O’Connell and were handled as previously
described (41). An antibiotic resistant strain of Escherichia coli ATCC 33456 harboring ampicillin
resistance (Amp R) on a pUC19-based vector, pEGFP (Invitrogen, Carlsbad, CA) was used in this
study. The pEGFP plasmid carries a gene for the green fluorescent protein (GFP) and a second
gene coding for beta-lactamase (bla) which provides resistance to the antibiotic ampicillin. A
second strain of E. coli, ATCC 33456 harboring spectinomycin resistance (SpecR) on a pUC18based vector, pUCSpec, was also used. The pUCSpec plasmid provides resistance to the antibiotic
spectinomycin. Both plasmids are from the same incompatibility group which reduces the chance
of a single cell holding both plasmids. All inocula were prepared from stock cultures stored at 80°C. The E. coli AmpR strain was maintained on Luria-Bertani (LB) agar containing 400 ppm
ampicillin, and the E. coli SpecR strain was maintained on LB agar containing 100 ppm
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spectinomycin. Both strains were cultured overnight (18-19 h) at 37ºC prior to use. Ampicillin and
spectinomycin stocks were obtained from Sigma-Aldrich, Inc. (St. Louis, MO)
To prepare an inoculum, several loopfuls of each E. coli strain were aseptically transferred
from each plate to their own 1 ml of sterile 50 mM phosphate buffer (pH 7.2). Cells were
resuspended by vortexing and pipetting. The optical density at 600 nm (OD600) of each overnight
suspension was measured by spectrophotometer (Pharmacia Biotech, New York, NY) and diluted
to achieve a 5:1 ratio of E. coli SpecR to E. coli AmpR as previously described (39). After obtaining
the desired optical density for the experiment, the combined inoculum was transferred into 100 ml
of phosphate buffer or LB broth.
2.2.2 Cultivation of biofilms
Flow-cell cultivation of biofilms was performed according to previously described
methods (42). Each strain was recirculated (attachment phase) through flow cells (46 × 4 × 2 mm)
alone or as co-cultures for 2 h in 50 mM phosphate buffer (pH 7.2) or LB broth at a flow rate of
0.84 ml min−1. A 5:1 ratio of various areal densities was used for these experiments based on
previously described methods (39).

For experiments involving antibiotic challenge during

recirculation, 80 ppm spectinomycin + 100 ppm ampicillin were supplemented in the recirculation
media. Following each recirculation period, flow cells were rinsed with 50 mM phosphate buffer
(pH 7.2) for 10 min. For microscopic analysis at 2 h, attached cells were stained with a 50 µM
solution of the red nucleic acid stain Syto 59 (Invitrogen, USA) for 10 min. followed by an
additional 5 min rinse using 50 mM phosphate buffer (pH 7.2). For 24 h biofilms, flow cells were
re-attached and switched to a continuous phase, supplemented with LB with or without antibiotics
(80 ppm spectinomycin + 100 ppm ampicillin) at a flow rate of 0.35 mL min−1 for the duration of
the experiment. Preparation for microscopic analysis after 24 h was the same as 2 h.
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2.2.3 Microscopy and image analysis
Colonized flow cells were imaged using a Zeiss LSM 510 confocal laser scanning
microscope (CLSM) (Carl Zeiss, Thornwood, NY) equipped with a Fluor 40× oil immersion lens.
Fluorescent excitation occurred simultaneously at wavelengths of 488 and 523 nm. A minimum
of four image stacks from each channel were taken at different locations throughout the flow cell,
using a 1-μm z-step increment. All data points for every experiment were measured in duplicate
or triplicate. Quantitative analysis of image stacks was performed using the statistical package
COMSTAT (43). Biovolume is quantified as biomass volume divided by substratum area
(µm3/µm2). It provides an estimate of the biomass in the biofilm and thus it is generally referred
to as biomass (43).
2.2.4 Statistical analysis
Initial mutualistic interactions were analyzed using and independent-samples KruskalWallis test (α=0.05). Experiments of effects of areal density and antibiotic exposure were analyzed
using a two-way analysis of variance (ANOVA) (α=0.05).
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2.3

Results

2.3.1 Community-dependent antibiotic tolerance and biofilm establishment
In establishing our model for evaluating interactions leading to biofilm establishment under
challenging conditions, we initially screened concentrations of antibiotics that were inhibitory and
suitable for our experiments. Concentrations of 80 ppm spectinomycin and 100 ppm ampicillin
were selected based on these preliminary experiments. To demonstrate these interactions, each E.
coli strain was recirculated independently of the other as well as in combination for 2 h in
phosphate buffer, allowing colonization of the flow cell. A ratio of 5:1 E. coli SpecR to E. coli
AmpR was used, with an approximate areal density of 600 cells (combined) and 500 (SpecR) and
100 (AmpR) cells separately. Subsequently, the cells were grown in LB + antibiotics for 24 h and
analyzed for biomass accumulation. CLSM and image analysis from 24 h biofilms indicated that
combined cultures of each E. coli strains resulted in significantly greater biomass accumulation
than each strain alone, in the presence of both antibiotics relative to untreated controls (Fig. 2.1A
and B).

These observations suggested that a favorable interaction between both strains in co-

culture allowed for biofilm formation to occur in the presence of a dual antibiotic challenge.
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Figure 2.1: Community-dependent biofilm establishment under antibiotic
challenge. (A) Top panel shows representative CLSM images of E. coli SpecR and E.
coli AmpR alone and in co-cultures, recirculated in phosphate buffer for 2 h. E. coli
SpecR appears red due to nucleic acid stain Syto 59, E. coli AmpR appears green due
to ampicillin-induced expression of green fluorescent protein (GFP). Bottom panel
represents growth condition in LB (± antibiotics) after 24 h. (B) The image analysis
software package COMSTAT was used for biomass determination and all conditions
were normalized to untreated controls. Values for each condition are means ±
standard error of the means for 2-3 replicates of each condition. An independentsamples Kruskal-Wallis test indicated a significant effect of culture condition (χ2(2) =
9.293, p<0.05) at 24 h. Asterisks indicate that mean rank values of E .coli SpecR and
E .coli AmpR are significantly different from the combined culture and untreated
controls.
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2.3.2 Effects of areal density and antibiotic exposure on biofilm formation under antibiotic
challenge: phosphate-recirculated cells
We hypothesized that three factors during recirculation (attachment) contributed to biofilm
growth by both E. coli strains in the presence of two inhibitory antibiotic concentrations, as seen
in Figure 2.1. These factors were areal density, the presence or absence of antibiotics, and the
presence or absence of nutrients. To determine the effect of areal density on biofilm growth, cocultured inocula of E. coli SpecR and E. coli AmpR were recirculated for 2 h in phosphate buffer
in the presence or absence of 80 ppm spectinomycin and 100 ppm ampicillin. The areal cell
densities selected for these experiments were 600, 900, and 1200 cells per microscopic field,
corresponding to x, y, and z cells mm-2 respectively. Additionally, based on optimal conditions
in previous findings (39) a 5:1 ratio of E. coli SpecR to E. coli AmpR was maintained with all
experiments. After the 2 h recirculation phase, attached cells were irrigated for 24 h with either
LB or LB supplemented with antibiotics (80 ppm spectinomycin + 100 ppm ampicillin). CLSM
and image analysis indicated no significant main effects of areal density or antibiotic exposure
(during recirculation) on biofilm biomass accumulation after 24 h, relative to controls (p > 0.05;
Fig. 2.2 A and B). This suggests that regardless of the areal density tested, using a 5:1 ratio at each
one was sufficient in overcoming any adverse effects of antibiotic exposure during attachment and
the 24 h period of biofilm development under antibiotic challenge. This may further suggest that
the importance of the community-dependent interactions that occur under challenging conditions
lies in the composition of the members of the biofilm community and their proximity to one
another.
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Figure 2.2: Effects of areal density and antibiotic exposure on phosphaterecirculated cells in 24 h biofilm formation. (A) Top panel shows representative
CLSM images of E. coli SpecR and E. coli AmpR co-cultures at a 5:1 ratio (~1200
cells), recirculated in phosphate buffer (+ antibiotics) for 2 h and grown in LB (±
antibiotics) for 24 h. Bottom panel is the same, except cells were recirculated in
phosphate buffer (-antibiotics). E. coli SpecR appears red due to nucleic acid stain
Syto 59, E. coli AmpR appears green due to ampicillin-induced expression of
green fluorescent protein (GFP). (B) The image analysis software package
COMSTAT was used for biomass determination and all conditions were
normalized to untreated controls. Values for each condition are means ± standard
error of the means for 3 replicates of each condition. Two-way ANOVA indicated
no significant main effects of either areal density or recirculation conditions. In
addition, no significant interaction between areal density and recirculation
conditions was determined.
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2.3.3

Effects of areal density and antibiotic exposure on biofilm formation under
antibiotic challenge: LB-recirculated cells
To determine whether the presence of nutrients during attachment impacted biofilm

formation, co-cultures of E. coli SpecR and E. coli AmpR were grown as described in Section 2.3.2
except that LB broth was provided during the 2 h recirculation. CLSM and image analysis
indicated a significant main effect of recirculation conditions (p < 0.05), but no significant effect
of areal density (p > 0.05). These data indicated that there was a significant difference in untreated
controls (no antibiotics at 2 and 24 h) and those that were recirculated in the presence or absence
of antibiotics, followed by a 24 h antibiotic challenge (Fig. 2.3 A and B). Nutrient availability
during the attachment phase, coupled with antibiotic exposure, did not appear to enhance antibiotic
tolerance during the following 24 h growth, relative to co-cultures recirculated in the absence of
antibiotics. Although nutrient availability during the attachment phase generally results in greater
overall biomass, it does not necessarily result in a significant advantage during biofilm
development under antibiotic challenge.
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Figure 2.3: Effects of areal density and antibiotic exposure on LBrecirculated cells in 24 h biofilm formation. (A) Top panel shows
representative CLSM images of E. coli SpecR and E. coli AmpR co-cultures at a
5:1 ratio (~1200 cells), recirculated in LB (+ antibiotics) for 2 h and grown in LB
(± antibiotics) for 24 h. Bottom panel is the same, except cells were recirculated
in LB (-antibiotics). E. coli SpecR appears red due to nucleic acid stain Syto 59,
E. coli AmpR appears green due to ampicillin-induced expression of green
fluorescent protein (GFP). (B) The image analysis software package COMSTAT
was used for biomass determination and all conditions were normalized to
untreated controls. Values for each condition are means ± standard error of the
means for 3 replicates of each condition. Two-way ANOVA indicated no
significant effect of the areal density factor (F [2, 96] = 0.190, p>0.05), but a
significant main effect of recirculation condition (F [2, 96] = 13.99, p<0.05); post
hoc tests show that untreated controls (no antibiotics at 2 and 24 h) were
significantly different from cells recirculated with our without antibiotics at 2 h
but challenged with antibiotics for 24 h (p<0.05). No significant interaction
between areal density and recirculation conditions was determined (F [4, 96] =
0.295, p>0.05).
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2.4

Discussion
The conditions present during substratum colonization are important factors in biofilm

formation, particularly in the presence of multiple antibiotics. The biofilm structure is inherently
resistant to biocidal treatments (5) and creates treatment hurdles that are further compounded by
the presence of antibiotic resistant populations within the biofilm community. Communitydependent antibiotic resistance allows for multiple members of a microbial community, each
harboring a unique antibiotic resistance gene, to coexist in close proximity in the presence of
inhibitory concentrations of antibiotics.

In evaluating these ecological interactions, it was

determined that the ability of antibiotic resistant co-cultures to establish biofilms under antibiotic
challenge occurred independently of areal density (i.e. number of attached cells during
recirculation). We suspect that the alleviation of the effects of antibiotic exposure is related to two
factors. This first is the proximity of each resistant cell type to one another, which facilitates the
likelihood of a mutual antibiotic detoxification event to take place. These types of interactions
were similarly observed by O’Connell and colleagues (40). The second factor is initiation of a
stringent response simulated by recirculation in phosphate buffer. The stringent response is a lownutrient stress response, which among others things, has been shown to regulate biofilm formation
in E. coli (44, 45). Phosphate-recirculated cells experience a period of starvation during the
attachment phase that may serve as an environmental trigger towards biofilm formation. This
occurs regardless of antibiotic exposure during the same period. Once cells were switched over to
a growth medium, biomass accumulation remains similar among all conditions after 24 h, perhaps
due to a slower growth rate of the cells in the biofilm as well as residual effects of the antibiotics.
It should also be noted that phosphate-recirculated cells grown in LB + antibiotics for longer
periods (~ 48 h) resulted in greater biomass accumulation (39), suggesting that even in the presence
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of an antibiotic challenge, given enough time, cooperative antibiotic detoxification will occur
resulted in greater biomass.
In contrast to the nutrient-poor conditions modeled during phosphate recirculation,
nutrient-rich conditions (LB) during the attachment phase generally resulted in increased biomass
accumulation after 24 h. This was not totally unexpected since nutrient availability during the
attachment phase would lead to rapid cell division and ultimately greater biomass accumulation
after 24 h, when compared to phosphate-recirculated cells. However, the presence or absence of
antibiotics during recirculation did not significantly help or hinder biofilm formation (24 h) under
antibiotic challenge. Initially it was hypothesized that antibiotic exposure during the attachment
phase might enhance biofilm formation by acting as an environmental cue, triggering cells to enter
into the more protective biofilm phenotype. This type of reaction to inhibitory concentrations of
antibiotics has been previously documented in both E. coli and P. aeruginosa and is linked to
secondary messenger systems like cyclic-di-GMP (27). However, these findings seem to indicate
that under nutrient-rich conditions the cells exposed to antibiotics do not fare any better than their
counterparts which go unchallenged during attachment. Nutrient availability, in fact, may actually
serve as a disadvantage to cells that experience antibiotic challenge. As it turns out, one of the key
characteristics that allows members of a biofilm to resist antimicrobial treatments is reduced
metabolic activity (46). Interestingly, Barraud et al. (47) similarly described how exposure to
mannitol enhanced the metabolic activity of P. aeruginosa biofilm cells and subsequently
enhanced their susceptibility to antibiotic treatment.
Although certain patterns were observed in our analysis of parameters like areal density
and antibiotic exposure, these patterns did not reveal any discernable significance within the scope
of our model. However, modifications to future experiments may help shed further light on the
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interplay between these factors. Additionally, nutrient availability, antibiotic exposure, and areal
density are certainly factors of clinical relevance when considering the ecological interactions that
occur in chronic infections caused by biofilms; however, one should also consider these parameters
when considering the use of biofilms as industrial catalyst. Conditions that initiate or promote
biofilm formation could be essential in biofilm reactor design and ultimately yield of final products
or removal of wastes (48).
The highlight of this method lies in its simplicity and reproducibility. The ability to
construct in vitro models of microbial biofilms of both clinical and industrial relevance can help
bridge the gap between bench-scale investigations and the ultimate application of therapeutic
strategies and full-scale industrial applications.
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3 Inhibition and dispersal of Pseudomonas aeruginosa biofilms by combination
treated of Escapin intermediate products and hydrogen peroxide.
3.1

Introduction
In their natural environments, microorganisms most frequently exist as biofilms, or

communities of microorganisms attached to surfaces and encased in a self-produced extracellular
matrix (29).

The properties of this matrix afford these microorganisms protection from

environmental challenges including nutritional starvation and chemical treatments such as
antibiotics. Biofilms have a well-documented impact in both industrial and clinical settings. In
microbial infections, the protective and recalcitrant nature of the biofilm state leads to problems
with treatment and clearance. Biofilms on medical devices such as catheters or implants can result
in chronic infections that are resistant to therapeutic drugs (49, 50). Nosocomial infections, often
associated with biofilm formation on medical devices or wound sites, contribute to higher
morbidity and mortality rates as well as increased healthcare costs (50, 51). Industries such as
wastewater treatment as well as food and agriculture are heavily impacted by the adverse effects
of biofilms as well (52, 53). Consequently, the search for effective anti-biofilm strategies is an
ongoing quest that looks to both natural and synthetic agents that are capable of preventing,
disrupting, or eradicating biofilms, while reducing selective pressures that contribute to resistance.
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An effective antimicrobial agent against planktonic microbes has been found in the ink of
the marine gastropod mollusc Aplysia californica (sea hare) (54). The ink is the product of two
simultaneously released glandular secretions; upon attack by predators, the sea hare releases both
products into the mantle cavity where they are mixed before being ejected from the animal (55,
56). One of the bioactive ingredients in the secretion is Escapin, an L-amino acid oxidase (25).
Escapin and its major natural substrate, L-lysine, are secreted at nearly 2 mg/ml and 150 mM
respectively (57-59). A series of Escapin-catalyzed and non-enzymatic chemical reactions yields
an equilibrium mixture of a diverse set of molecules referred to as Escapin intermediate products
(EIP), which can be synthesized and are effective as naturally produced products (Fig. 3.1) (1, 60).
Hydrogen peroxide (H2O2) and ammonium are also produced. The equilibrium among the
components of EIP is dependent on pH, with the cyclic form, compound 3, dominating at any pH.
The combination of EIP and H2O2, annotated as “EIP + H2O2” throughout this work, is
bactericidal against a wide range of planktonic microbes including Gram-negative and Grampositive bacteria, yeast, and fungi (1, 25). At low millimolar concentrations, EIP + H2O2 produces
rapid, powerful, and long lasting bactericidal activity against planktonic cells, probably through
condensation of DNA (1, 28). EIP + H2O2 is an especially effective agent against planktonic
cultures of P. aeruginosa (1). Given the bactericidal effects of EIP + H2O2 against planktonic
bacteria, and in particular P. aeruginosa, we focused on the effectiveness of EIP + H2O2 against
bacterial biofilms. P. aeruginosa is a well-known opportunistic pathogen whose biofilms cause
chronic infections, morbidity, and mortality (61-63). Taking into account the effectiveness of EIP
+ H2O2 against this bacterium (1) and its clinical relevance as a formidable pathogen, the objective
of this study was to determine the effectiveness of EIP + H2O2 in preventing the formation of and
disrupting existing biofilms of P. aeruginosa.
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Figure 3.1: Summary of the chemistry of the reaction of Escapin with L-lysine,
including the effects of pH on the relative composition of the molecular species in
the equilibrium mixture. Figure reprinted with permission from Ko et.al. 2008 (1).
Compounds are: L-lysine (compound 1), α-keto-ε-aminocaproic acid (compound 2), Δ1piperideine-2-carboxylic acid (compound 3), Δ2-piperideine-2-carboxylic acid
(compound (4), γ-aminovaleric acid (compound 5), γ-valerolactam (compound 6), 6amino-2-hydroxy-hex-2-enoic acid (compound 7), 6-amino-2,2-dihydroxy-hexanoic
acid (compound 8), and 2-hydroxy-piperidine-2-carboxylic acid (compound 9).

3.2

Materials and Methods

3.2.1 Culture preparation
Pseudomonas aeruginosa PAO1 was grown in Pseudomonas Basal Mineral Medium,
supplemented with glucose (80 mM final concentration) (PBM-glucose) (64) at 37 °C with shaking
at 200 rpm for 16-18 h. Frozen stocks (10% glycerol/-80 °C) were thawed and 35 μl were added
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to 30 ml of PBM-glucose in a 50 ml flask. Overnight cultures were diluted with fresh PBMglucose to obtain initial inoculum densities of OD600 = 0.01 or 0.10 for biofilm formation and
dispersal assays, respectively.
3.2.2 Chemicals
Escapin intermediate products (EIP) was synthesized as described in Kamio et al. (60)
based on Lu and Lewin (65) using a non-enzymatic synthesis starting with pipecolinic acid ethyl
ester. Δ1-Piperidine-2-carboxylic acid (compound 3) is the major product and Δ2-piperidine-2carboxylic acid (compound 4) is the minor product of this synthesis, though in solution,
compounds 3 and 4 form an equilibrium mixture with other compounds, as shown in Figure 3-1.
The preparation of EIP used in each treatment is derived from the synthetic preparation of 𝜟1piperidine-2-carboxylic acid and used as the initial molecule to generate the EIP equilibrium
mixture. This synthesis allows for the independently controlled presentation of these two major
components of Escapin’s products, EIP and H2O2. Freeze-dried EIP was stored at -80 °C and
dissolved in sterile deionized (DI) water as a 1 M stock and diluted at the time of experiment.
Hydrogen peroxide (H2O2, 30%) was purchased from Fisher Scientific (Cat. No. H325-100). For
experiments, treatment concentrations of EIP and H2O2 were prepared in Pseudomonas Basal
Mineral Medium without glucose (PBM-no glucose) in order to prevent further growth during
treatment periods.
Live/Dead® BacLight™ Bacterial Viability Kit (L-7012) was purchased from Life
Technologies (CA, USA). This kit includes two different nucleic acid stains: SYTO 9® and
propidium iodide (PI). SYTO 9® is a green-fluorescent dye that labels bacteria with either intact
or damaged membranes. PI is a red-fluorescent dye that can only penetrate bacteria with damaged
membranes and that reduces SYTO 9® fluorescence when both dyes are present.
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3.2.3 Assay of biofilm formation
Biofilms were cultured in 96-well polystyrene microtiter plates (20, 66, 67) using PBMglucose as the growth medium. Briefly, biofilms were grown for 5 h (attachment phase) in the
presence of EIP + H2O2, EIP alone, H2O2 alone, and PBM-glucose alone as the control. After
incubation and treatment periods, biofilms were rinsed with sterile, deionized (DI) water by
consecutively submerging microtiter plates in three separate tubs for 10 sec each, followed by
shaking out extra water. The biofilms were stained with 125 μl of 0.02% crystal violet (125 μl
0.3% crystal violet (Becton Dickinson, NJ) in 2 ml DI water) for 15 min at room temperature with
shaking at 200 rpm. After staining, 96-well plates were rinsed with DI water three times. Plates
were allowed to air dry for a minimum of 1 h or overnight. For quantification, bound crystal violet
was dissolved with 125 μl of 95% ethanol for 30 min at room temperature with shaking at 200
rpm. Absorbance of dissolved crystal violet was measured by spectrophotometer at 570 nm using
95% ethanol as the blank. Treatment conditions were normalized to untreated controls and biofilm
inhibition, as determined by biomass accumulation, is expressed as biomass (% control).
3.2.4 Assay of biofilm dispersal
Biofilms were grown in flow cells as described previously (20, 42, 68) using PBM-glucose
as the growth medium. Frozen stocks of strain PAO1 were inoculated (35 μl added to 30 ml
medium) into PBM-glucose in a 50 ml flask and incubated at 37 °C with shaking at 200 rpm for
16-18 h. The overnight culture was diluted with fresh PBM-glucose to obtain an OD600 of 0.10.
Biofilms were grown in flow cells for 20 h in recirculation mode and were rinsed for 20 min with
PBM-no glucose (rinse buffer). Biofilms were then treated with EIP + H2O2, EIP alone, H2O2
alone, or a PBM-no glucose control for 30 min followed by a 10 min rinse with PBM-no glucose
prior to staining. One ml of a staining solution consisting of LIVE/DEAD® BacLight™ Bacterial
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Viability Kit (3.34 µM SYTO 9 and 20 µM propidium iodide) was used to stain the biofilm for 15
min, followed by a 5 min rinse with PBM-no glucose. Microscopic imaging of each flow cell was
performed using a Zeiss LSM 510 confocal laser-scanning microscope (Carl Zeiss, Thornwood,
NY). A minimum of 10 image stacks with a 1 μm z-step were taken for each channel of the flow
cell using a 40× oil immersion lens. The excitation/emission wavelengths of 480/500 nm and
490/635 nm were used for SYTO 9 and propidium iodide, respectively, using argon and heliumneon (HeNe) lasers. Quantitative analysis of image stacks was performed using the statistical
package COMSTAT (43). Biovolume is quantified as biomass volume divided by substratum area
(µm3/µm2). It provides an estimate of the biomass in the biofilm and thus it is generally referred
to as biomass (43). Area layer is the fraction of the area occupied by biomass (%) in each image
of a stack (i.e. distance from the substratum (µm)) (43). Image stacks are 1 µm slice images that
are stacked by the CLSM program to generate a three dimensional image of the biofilm. Area
layer analysis determines what fraction of each 1-µm slice is occupied by biomass from the
substratum to the apex of the biofilm.
3.2.5 Motility assays
Motility assays were performed as described previously (69, 70) with some modification.
Media used for the assay was Luria-Bertani (LB) broth, Miller (Difco) (tryptone 10 g/l, yeast
extract 5 g/l, sodium chloride 10 g/l) (Fisher Scientific Cat. No. DF0446-07-5) containing 0.3%
(wt/vol) Bacto agar (Fisher Scientific Cat. No. DF0140-15-4) for swimming, 0.5% (wt/vol) Bacto
agar for swarming, and 1% (wt/vol) for twitching plates. For initial screens of effects of EIP on
motility, 10 µl of either PBM-no glucose (control) or various concentrations of EIP (50, 100, 200,
400, 800, 1000 µM) (treatment) were spotted at the center of each corresponding motility plate
and allowed to dry for approximately 5-10 min prior to inoculating bacteria. In subsequent
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swimming motility experiments, EIP (50 µM or 100 µM), H2O2 (3 µM or 6 µM), or EIP + H2O2
(3 µM H2O2 + 50 µM EIP or 6 µM H2O2 +100 µM EIP) were applied to each plate in the same
manner. To account for the single 10 µl application of EIP and H2O2, as compared to the constant
flow presented in flow cell treatments, higher concentrations of each compound were tested, also
taking into account diffusion of the compound through the agar matrix as well as the possibility of
chemical instability. Swimming and swarming plates were gently inoculated at the agar surface
at the center of each plate with bacteria from an overnight culture streaked on LB agar plates (1.5%
wt/vol) using sterile toothpicks. Twitching plates were inoculated by stabbing the toothpick
through the agar at the center of each plate, making sure to make contact with the bottom surface
of the plate. Plates were sealed with Parafilm to prevent dehydration and incubated at 37°C for
24 h. The diameter (measured in mm) of the motility zone was measured at intervals of 2, 4, and
24 h and used to determine the area (mm2) of the zone. Treatments were normalized to the mean
values for each replicate of the untreated controls and motility zones are expressed as area (%
control).
3.2.6 Statistical analysis
Prevention of biofilm formation was analyzed using two-way analysis of variance
(ANOVA) (α=0.05). Analysis of biofilm dispersal and undamaged/damaged ratios were done
using one-way ANOVA (α=0.05). A repeated measures ANOVA (α=0.05) was used in
analyzing area layer data. Motility experiments were analyzed using an independent-samples t
test (α=0.05) and independent-samples Kruskal-Wallis test (α=0.05).
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3.3

Results

3.3.1 EIP + H2O2 in combination inhibit P. aeruginosa biofilm formation at micromolar
concentrations
Preliminary data collected to determine effective concentrations of EIP and H2O2 for
biofilm prevention studies indicated that micromolar concentrations of both EIP and H2O2 were of
particular interest. To examine these conditions further, P. aeruginosa was grown in microtiter
plates for 5 h, simulating the attachment phase of the biofilm life cycle, in the presence of varying
concentrations of H2O2 alone, EIP alone, or EIP + H2O2 (Fig. 3.2). H2O2 alone resulted in reduced
biofilm formation, particularly at the concentrations of 48 µM and 96 µM which resulted in an
approximate 44% and 30% reduction in biomass, respectively, relative to untreated controls. EIP
alone, at either 3 µM or 30 µM, resulted in 25% and 17% less biofilm formation respectively,
compared to untreated controls. EIP + H2O2, at H2O2 concentrations ≥ 24 µM, resulted in up to
47% less biofilm formation relative to untreated controls. The greatest effect on biofilm formation
was observed when EIP was paired with 96 µM H2O2, resulting in more than 65% less biofilm
formation, relative to untreated controls. Two-way ANOVA indicated a significant treatment
effect (H2O2, 3 μM EIP + H2O2, 30 μM EIP + H2O2) and a significant concentration effect (H2O2
at 0 to 96 μM) but a non-significant treatment-concentration interaction. Post hoc analysis of the
treatment effect indicated that combination treatment of EIP (3 µM or 30 µM) + H2O2 resulted in
significantly less biofilm formation than single treatments.

Post hoc analysis of the H2O2

concentration effect showed that higher concentrations resulted in significantly less biofilm
formation than lower concentrations. Thus, while EIP and H2O2 alone only resulted in 20 to 30%
less biofilm formation than the untreated controls, EIP (3 µM or 30 µM) + H2O2 (96 µM) resulted
in nearly 70% less biofilm formation than the control. The effects of EIP and H2O2 were assessed

26

after 12 h to determine if inhibition of biofilm formation was maintained (data not shown).
However, the inhibitory effects diminished over this period, most likely due to a reduction in the
chemical stability of the EIP.

Figure 3.2: Effects of EIP and H2O2 on P. aeruginosa biofilm formation.
P. aeruginosa biofilms were grown for 5 h in the presence of varying concentrations
of: H2O2 alone (black bars); 3 µM EIP alone or in combination with H2O2 alone
(gray bars); or 30 µM EIP alone or in combination with H2O2 (white bars). Negative
control (untreated) was PBM-glucose. Prevention of biofilm formation was
determined by 96-well microtiter plate crystal violet assay. The values for each
treatment including control (PBM-glucose) are means ± standard errors of the means
for three replicates for each experimental condition. Total number of measurements
for each treatment ranged from 23-48. Two-way ANOVA indicated a significant
effect for the treatment factor (F [2,473] = 18.57, p<0.05); post hoc tests show that the
H2O2 alone treatment is significantly different from H2O2 + 3 µM EIP and H2O2 +
30 µM EIP (p<0.05). Additionally, a significant effect was determined for the H2O2
concentration factor (F [6,473] = 11.43, p<0.05; post hoc tests show that the values for
0 µM =3 µM = 6 µM (a) > 12 µM = 24 µM (b) > 48 µM = 96 µM (c). The interaction
between the treatment factor and the H2O2 concentration factor was not significant
(F [12,473] = 0.91, p>0.05).
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3.3.2 EIP and H2O2 work synergistically to disperse P. aeruginosa biofilms
To examine the dispersal effects of EIP + H2O2 on established biofilms, a range of
concentrations of H2O2 plus one concentration of EIP (50 µM) were tested using biofilms
cultivated in flow cells for 20 h. Preliminary experiments (data not shown) indicated various EIP
concentrations (above and below our treatment condition) that resulted in biofilm disruption; a
concentration of 50 µM resulted in more pronounced disruption when paired with H2O2 and thus
was selected as the treatment concentration. Representative CLSM images of 20 h old biofilms
treated with 3 µM H2O2 alone, 3 µM H2O2 + 50 µM EIP, and 50 µM EIP alone show the disruptive
effects of the combined treatment versus H2O2 or EIP alone (Fig. 3.3A). The combined treatment
resulted in greater biomass clearance (indicated by black color (no cells)) and less stained biomass
(yellow) compared to the control and other treatments (Fig. 3.3A). One-way ANOVA showed
that combination treatments, including the combinations of 50 µM EIP plus either 0.03 µM H2O2
or 3 µM H2O2, but not the respective single treatments, significantly reduced biofilm biomass, by
42% and 37% respectively, relative to control levels (Fig. 3.3B). Treatments with 30 µM and 300
µM H2O2 alone, were not significantly different than their corresponding combined treatments
with 50 µM EIP, suggesting a small window of concentrations ranges in which synergistic effects
take place.
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Figure 3.3: Effects of EIP on P. aeruginosa and biofilm cell viability and biomass.
Representative confocal microscopy images of 20 h P. aeruginosa biofilms following treatment with 3
µM H2O2 alone, 50 µM EIP alone, 3 µM H2O2 + 50 µM EIP, and control (PBM-no glucose). Shown is
cell viability labeling using LIVE/DEAD® BacLight™ nucleic acid stain where green labeling
represents live and undamaged cells, red labeling represents cells that are dead or with damaged
membranes, yellow represents areas where green and red labeling are co-localized in the biofilm and
black labeling represents area without cells. Bottom panel shows representative 3-dimensional
projections of the representative confocal images. Scale bar, 50 µm. (B) Effects of EIP + H2O2 against
P. aeruginosa biofilm (i.e. biofilm disruption). Flow-cell cultivated P. aeruginosa biofilms (20 h) were
analyzed post-treatment by CLSM. The image analysis software package COMSTAT was used for
biomass determination and all treatments were normalized to untreated controls. Open diamond is
untreated control; open square is 50 µM EIP alone; open circles are H2O2 alone; closed circles are EIP +
H2O2. Values are means ± standard errors of the means for three replicates for each experimental
condition. A range of 5 to 10 image stacks were taken for each biofilm; the total number of measurements
for each treatment ranged from 4-172. ANOVA showed that the 7 treatments significantly differ in their
effect on biofilm biomass (F [12,472] = 8.21, p<0.05), and post hoc tests show that EIP + H2O2 but not EIP
or H2O2 is significantly different from the control (p<0.01). Asterisks indicate that the value of the EIP
+ H2O2 at concentrations of 0.03 µM or greater and H2O2 alone at 30 µM and 300 µM is significantly
lower than that of untreated control and EIP + H2O2 at concentrations ≤ 0.003 µM.

3.3.3 Treatment with EIP or EIP + H2O2 disperses but does not increase membrane
damage within P. aeruginosa biofilm.
The ability of EIP + H2O2 to cause membrane damage and impact viability of biofilm cells
was assessed by measuring the ratio of green to red stained cells in biofilm images collected by
CLSM. One-way ANOVA indicated that treatment with 3 µM H2O2 + 50 µM EIP or 50 µM EIP
alone significantly reduced biofilm biomass compared to untreated controls and treatments with 3
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µM H2O2 alone (Fig. 3.4A). Measurements of green and red biomass from these treatments were
used to determine a ratio of undamaged to damaged cells to determine the impact of treatment on
membrane integrity (Fig. 3.4B). An undamaged/damaged ratio less than one is indicative of a
greater presence of damaged cells. The undamaged/damaged ratios for all treatments, including
the untreated control, were all greater than two, suggesting that the effects of the treatments did
not result in increased membrane damage to the biofilm cells. The undamaged/damaged ratios for
3 µM H2O2 + 50 µM EIP and 3 µM H2O2 were not significantly different from the untreated
control, and the undamaged/damaged ratio for 50 µM EIP was significantly greater than all other
treatments. Taken together with our other results, these experiments support the idea that EIP and
H2O2 are dispersive, but not through a mechanism of membrane damage.
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Figure 3.4: Effects of EIP and H2O2 on P. aeruginosa biofilm disruption. (A) Flow-cell cultivated biofilms were
analyzed post-treatment by CLSM. The image analysis software package COMSTAT was used for biomass
determination and all treatments were normalized to untreated controls. Values are means ± standard errors of the
means for three replicates. Ten image stacks were taken for each biofilm; the total number of measurements for each
treatment ranged from 30-109. ANOVA showed that two treatments significantly differ in their effect on biofilm
biomass (F [3,205] = 10.24, p<0.05); post hoc tests show that 3 µM H2O2 + 50 µM EIP and 50 µM EIP but not 3 µM
H2O2 are significantly different from the control (p<0.05). Asterisks indicate that the values for 3 µM H2O2 + 50 µM
EIP and 50 µM EIP are significantly lower than the values for the untreated controls and 3 µM H2O2. (B)
Undamaged/damaged ratios were derived by dividing green biomass measurements by red biomass measurements.
Treatments evaluated were 3 µM H2O2, 50 µM EIP, 3 µM H2O2 + 50 µM EIP, and untreated controls. ANOVA
showed that the undamaged/damaged ratio significantly differs across the treatments (F [3,233] = 2951.10, p<0.05);
post hoc tests show that the undamaged/damaged ratio for 50 µM EIP was significantly different from all other
treatments (p<0.05). (C) Area layer was determined by COMSTAT analysis and is a measurement of the fraction of
the area occupied by biomass (%) in each image of a stack (i.e. distance from the substratum (µM)). The differences
in the mean area layer of biofilms in each treatment group relative to biofilms of untreated controls were used to
determine how the biofilm structure (from substratum to apex) was affected by our treatments. A repeated measures
ANOVA showed a significant effect on area layer by treatment condition; post hoc tests showed that treatments of 3
µM H2O2 + 50 µM EIP and 50 µM EIP were significantly different than treatment with 3 µM H 2O2 alone.
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3.3.4 EIP and EIP + H2O2 disrupt the biofilm structure from substratum to apex
Comparison of biofilm biomass after treatment with H2O2, EIP, and EIP + H2O2 revealed
that the combination treatment of these compounds resulted in significant dispersal of P.
aeruginosa biofilms, relative to untreated controls (Fig. 3.4A). To determine if EIP + H2O2 affects
the biomass distribution within the biofilm, the area layer function of COMSTAT was used to
analyze CLSM-derived image stacks. Area layer measures the fraction of the area occupied by
biomass (%) in each image of a stack as a function of distance from the substratum. By calculating
the differences in the mean area layer of biofilms in each treatment group relative to biofilms of
untreated controls, we determined how the biomass distribution within the biofilm was affected by
the treatments (Fig. 3.4C). Treatment with 3 µM H2O2 + 50 µM EIP or with 50 µM EIP led to a
significant decrease in biomass from substratum to apex relative to the untreated controls. On the
other hand, 3 µM H2O2 alone caused biomass accumulation near the substratum relative to
untreated controls.
3.3.5 EIP and EIP + H2O2 enhances P. aeruginosa swimming motility
To determine if biofilm dispersal, in the absence of increased membrane damage, was
mediated through a motility mechanism, a series of agar plate-based motility assays were
performed to test the effects of EIP on swimming, swarming, and twitching motility. Initially, a
concentration of 1 mM EIP was tested in order to account for the diffusion of the compounds
through the agar matrix as well as compound stability over the duration of the assay. These
preliminary experiments showed that exposure to 1 mM EIP did not enhance or inhibit swarming
or twitching motility; however, swimming motility was significantly enhanced relative to
untreated controls (data not shown). Subsequently, a series of EIP concentrations below 1 mM
was tested (50, 100, 200, 400, 800 µM) to identify the range of effective treatment concentrations.
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Motility was monitored over a period of 2 and 4 h to determine the duration of any effects.
Exposure to 50 µM EIP did not result in a significant increase in swimming motility relative to
untreated controls (Fig. 3.5). However, only a 2-fold increase in concentration (100 µM EIP) was
required to significantly enhance swimming motility relative to untreated controls. This effect was
observed over the course of 4 h (Fig. 3.5B). To determine the combined effects of EIP + H2O2 on
motility, concentrations used in biofilm dispersal assays (3 µM H2O2 and 50 µM EIP) were tested
either alone or in combination, but they did not result in any enhancement in swimming motility
over the course of 4 h (data not shown). However, by increasing the H2O2 concentration 2-fold (6
µM), its combined effect with 100 µM EIP enhanced P. aeruginosa swimming motility
significantly (~80% after 2 h; ~40 % after 4 h), compared to each treatment alone and untreated
controls (Fig. 3.6).
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Figure 3.5: Effects of EIP on motility at 2 and 4 h. (A) Effects of 50, 100, 200, 400, and
800 µM EIP on P. aeruginosa swimming motility after 2 h at 37°C. Swimming motility
for each treatment was quantified by measuring the diameter (mm) of each motility zone
and calculating the area (mm2) of each zone after incubation. Treatments are as follows:
untreated control (PBM-no glucose) (black bar), 50 µM EIP (checkered bar), 100 µM EIP
(dark gray bar), 200 µM EIP (light gray bar), 400 µM EIP (white bar), and 800 µM EIP
(diagonal bar). Values are means ± standard errors of the means for three replicates for
each experimental condition. Treatments were normalized to untreated controls after taking
the mean of the values for each of the control replicates. An independent-samples KruskalWallis test indicated a significant effect of treatment on swimming motility (χ2(5) = 40.118,
p<0.05) at 2 h. Asterisk indicates that the mean rank values for treatments ≥ 100 µM EIP
were significantly different than the mean rank values for the untreated control and 50 µM
EIP (p<0.05). (B) Same as panel A, except for 4 h incubation time rather than 2 h. The
Kruskal-Wallis test indicated a significant effect of treatment on swimming motility (χ2(5)
= 40.399, p<0.05). Asterisk indicates that the mean rank values for treatments ≥ 100 µM
EIP were significantly different than the mean rank values for the untreated control and 50
µM EIP (p<0.05).
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Figure 3.6: Effects of EIP + H2O2 on motility at 2 and 4 h. (A) Effects of 6 µM H2O2 +
100 µM EIP on P. aeruginosa swimming motility at 2 h at 37°C. Swimming motility for each
treatment was quantified by measuring the diameter (mm) of each motility zone and
calculating the area (mm2) of each zone after incubation. Treatments are as follows: untreated
control (PBM-no glucose) (black bar). 100 µM EIP (dark gray bar), 6 µM H2O2 + 100 µM
EIP (light gray bar), and 6 µM H2O2 (white bar). Values are means ± standard errors of the
means for two replicates for each experimental condition. Treatments were normalized to
untreated controls after taking the mean of the values for each of the control replicates. An
independent-samples Kruskal-Wallis test indicated a significant effect of treatment on
swimming motility (χ2(3) = 30.251, p<0.05) at 2 h. Asterisk indicates that the mean rank
value for the 6 µM H2O2 + 100 µM EIP treatment was significantly different than the mean
rank values for each compound alone and the untreated control (p<0.05). (B) Same as panel
A, except for 4 h incubation time rather than 2 h. The Kruskal-Wallis test indicated a
significant effect of treatment on swimming motility (χ2(3) = 14.530, p<0.05) at 4 h. Asterisk
indicates that the mean rank value for the 6 µM H2O + 100 µM EIP treatment was
significantly different than the mean rank values for each compound alone and the untreated
control (p<0.05).
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3.4

Discussion
Our results show that EIP + H2O2 acts in combination against P. aeruginosa biofilms at

micromolar concentrations in two ways: prevention of biofilm formation and disruption of
established biofilms. Preventing biofilm formation is an important anti-biofilm strategy, and it
encompasses the use of compounds that modulate gene expression linked to virulence factors, cellto-surface adhesion, and interference with exopolysaccharide production (71). However, in many
cases, the specific mechanisms of agents that prevent biofilm formation have yet to be elucidated.
The extent of biofilm inhibition caused by EIP + H2O2 is similar to the biofilm inhibiting effect
caused by the Bacillus subtilis S8-18-derived α-amylase, a type of hydrolase that prevented biofilm
formation in P. aeruginosa and other pathogens (72). As is the case with α-amylases, EIP + H2O2
could play a direct role in inhibiting biofilm formation by interference with bacterial adhesion,
which is a critical step in initial biofilm formation and has been shown to occur within the first
several hours in P. aeruginosa (73). There is an ecological interpretation for the biofilm prevention
activity of EIP + H2O2: Escapin, the L-amino acid oxidase from which EIP is derived, is a paralog
of aplysianin A, an L-amino acid oxidase used by the sea hare A. californica to prevent microbial
biofouling of its egg capsules (28, 58, 74).
A notable finding of this work is the ability of H2O2 to inhibit P. aeruginosa biofilm
formation at micromolar concentrations. This is of particular interest due to the fact that millimolar
concentrations are commonly used to trigger sublethal effects of oxidative stress in P. aeruginosa
(75). P. aeruginosa is adapted to detect and overcome oxidative stress, particularly at these low
millimolar concentrations (76, 77). Low millimolar concentrations of H2O2 have been shown to
actually enhance biofilm formation, most likely through a quorum sensing mechanism (78).
Transcriptomic analyses have shown that exposure to H2O2 results in an increase in mRNA levels
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of genes necessary to deal with oxidative stress as well as virulence factors (75). These adaptive
capabilities are not unique to P. aeruginosa. Salmonella enterica Typhimurium becomes resistant
to H2O2 treatments as high as 10 mM after exposure to sub-lethal concentrations of H2O2 (60 µM)
(79). Similar observations have also been reported in Escherichia coli (80). However, here we
have identified concentrations of H2O2 that when paired with EIP, inhibit biofilm formation at
levels far below those commonly tested against P. aeruginosa.
Oxidizing agents such as H2O2 have well-documented antimicrobial effects through DNA
damage and oxygen radical toxicity (81, 82). The antimicrobial effects are often more pronounced
in planktonic cells as they are genotypically and phenotypically different from their biofilm
counterparts and are generally more susceptible to treatments (77, 83). In fact, this same pattern
of susceptibility was observed in our antimicrobial treatment in that EIP + H2O2 was more effective
against planktonic cultures of P. aeruginosa (1, 84). In addition to inhibiting biofilm formation,
the combination of EIP and H2O2 is effective against established P. aeruginosa biofilms at
micromolar concentrations, which is at or below concentrations often used in published treatment
assessments. For example, Stewart et al. (77) showed that a steady treatment of 50 mM H2O2 for
1 h had little effect on wild-type P. aeruginosa biofilms, a result linked to the combined effects of
reduced penetration of the compound through the biofilm matrix and the protective role of catalase
production in the biofilm. Similarly, Bjarnsholt et al. (85) treated established P. aeruginosa
biofilms with 100 mM H2O2 and demonstrated a decrease in susceptibility, most likely due to a
quorum sensing mechanism. Although microbial biofilms are generally less susceptible to the
effects of H2O2, specifically at concentrations in the low millimolar range, our results suggest a
treatment strategy in which H2O2 is effective at micromolar concentrations.
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Disrupting established biofilms is a critical anti-biofilm strategy in applied contexts.
Several factors promote detachment of P. aeruginosa, including enzymatic disruption of the
surrounding extracellular polymeric substance (EPS) matrix, oxygen radical-dependent killing of
bacteria (86), prophage-mediated bacterial death that enhances dispersal of cells from the biofilm
(62), or the release of amyloid fibers linking cells in the biofilm together, a process regulated by
D-amino acids (87). Area layer analysis indicated that introduction of EIP, either alone or in
combination with H2O2, significantly affected biofilm structure down to the substratum. The fact
that treatment with H2O2 alone appeared to have no significant structural effect on the biofilm was
not completely unexpected. In fact, H2O2-mediated cell lysis has been shown to contribute to
extracellular DNA (eDNA) release in P. aeruginosa biofilms (88). This eDNA release, coupled
with poor penetration of the H2O2 through the biofilm matrix or its inactivation by catalases, could
account for the largely unchanged biofilm structure, particularly at the substratum.

The

introduction of EIP, on the other hand, either alone or in combination with H2O2, significantly
affects biofilm structure, specifically down to the substratum. EIP may not be susceptible to the
same inactivation mechanisms seen with H2O2, which would allow it to penetrate and disrupt the
biofilm matrix more effectively. Since previous work with EIP in planktonic cultures suggested
DNA condensation as a mechanism underlying its bactericidal properties (28), we initially
hypothesized that EIP may be affecting the structural stability of the biofilm matrix by targeting
the eDNA. This is of particular importance because eDNA is an important structural component
to P. aeruginosa biofilms and has been viewed as a viable target for biofilm disruption using
enzymes such as DNase (89). However, the possibility of EIP initiating biofilm dispersal through
a motility-dependent mechanism was also considered. Bacterial motility such as swimming,
swarming (flagella-mediated) and twitching (type IV pili-mediated) are essential in P. aeruginosa
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biofilm formation and maturation (90). In fact, the enhancement of P. aeruginosa motilities, such
as swimming, and its subsequent role in biofilm dispersal by compounds such as nitric oxide (91)
and ginseng extracts (69) are well documented. Interestingly, we determined that exposure to 1
mM EIP significantly enhances swimming motility in P. aeruginosa when compared to untreated
controls. Follow-up experiments showed that concentrations as low as 100 µM EIP resulted in
enhanced swimming motility relative to untreated controls, while pairing of 6 µM H2O2 + 100 µM
EIP enhanced swimming motility to a greater degree than either compound alone. This effect was
observed over a period of 4 h and provides further support to the effectiveness of these compounds.
Altogether, the coupling of EIP with hydroxyl radicals generated by H2O2, which have also been
shown to trigger DNA damage (81, 92), results in a significant dispersal effect to established P.
aeruginosa biofilms.
There is additional significance in that the presence of endogenous H2O2 in the biofilm
environment has been documented. Liu et al. (93) measured H2O2 concentrations in the range of
0.7–1.6 mM in Streptococcus gordonii biofilms and suggested that H2O2 concentrations can vary
by species composition. Likewise, many oral streptococci produce H2O2 as a means of competitive
advantage (94). The production of oxygen radicals, including H2O2 by polymorphonuclear
leukocytes (PMNs) as means of eradicating microbial infections, is yet another potential source of
endogenous H2O2 that could be encountered within a biofilm environment (85). Thus, introduction
of EIP alone could potentially enhance the inherent disruptive effects of H2O2 in these
environments.
EIP + H2O2 is a potentially valuable therapeutic for anti-virulence strategies, because it
negatively impacts biofilm development and promotes dispersal at sub-lethal concentrations.
Anti-virulence strategies are currently being pursued to overcome widespread microbial multi-
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drug resistance (14). In general, these strategies aim to control microbial pathogenesis by targeting
virulence mechanisms (e.g. cell adhesion, quorum sensing, biofilm formation, toxin production)
while minimizing the selective pressure on the microorganisms that often leads to resistance (14,
95). Further investigation into the potential application of these compounds in combination with
existing treatment strategies is both warranted and the focus of future work.
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4

CONCLUSIONS

Over the past twenty years, microbial biofilms have been investigated for their significant
impact in both clinical and industrial settings (2). The biofilm lifestyle allows microorganisms to
colonize and establish complex communities in diverse environments. It is important, therefore,
to understand the factors that promote biofilm formation and maturation. During the course of our
investigations, we relied on methods for constructing polymicrobial biofilms with defined
compositions in order to test various hypotheses regarding factors that influence biofilm
establishment under antibiotic challenge. Surface colonization is an important step in the biofilm
formation process. The amount of cells that colonize a given surface can ultimately affect the
development of the biofilm as it matures, particularly under antibiotic pressure.

Nutrient

availability also plays an important role in the biofilm lifestyle. The presence or absence of
nutrients can serve as an environmental cue, triggering phenotypic changes in cells that make them
more or less resistant to antimicrobial treatments. Future directions taking advantage of our
described methods would be ideal for studying interactions between biofilms comprised of
multiple pathogens. For example, the sputum of cystic fibrosis patients has been characterized to
contain pathogens such a P. aeruginosa and Staphylococcus aureus (96). Indwelling devices, such
as catheters, have also been shown to be colonized by various pathogens. Thus, modeling biofilm
interactions is of extreme value, taking into consideration the mounting negative impact that
biofilms and antibiotic resistance have on global health.
Strategies to combat rising levels of antibiotic resistance are driven by the increases in
multi-drug resistance in pathogenic bacteria. Another major part of our investigation was to
determine the efficacy of the novel antimicrobial treatment combination, EIP + H2O2, towards
bacterial biofilms. The combination of these compounds was previously determined to be
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effective against planktonic cultures of bacteria. Using P. aeruginosa as a model organism, we
found that combination treatments of EIP + H2O2 were effective at inhibiting early biofilm
formation as well as dispersal of pre-formed biofilms. A key distinction of our findings was that
treatment concentrations of our compounds were effective at the micromolar range, far below the
millimolar ranges previously observed on planktonic cultures. For both biofilm inhibition and
biofilm dispersal, combining EIP + H2O2 was more effective than each compound alone,
suggesting a synergistic interaction between the compounds. Inhibition was observed during early
biofilm formation (< 4 h) at nearly 70% of untreated controls. Biofilm dispersal of 24 h biofilms
was observed at nearly 40% of untreated controls after only a 30 min treatment. The role of EIP
as a potential novel treatment strategy is particularly attractive due to its synergistic activity with
H2O2, especially at low concentrations. Hydrogen peroxide is readily encountered in microbial
environments, particularly at wound sites, and therefore it may be possible to deliver EIP to wound
sites and allow it to work with endogenous concentrations of H2O2.
Based on calculated ratios of membrane damage (live/dead staining), we were able to
determine that dispersal was not due to a bactericidal effect of the compounds. In the absence of
a bactericidal effect to account for dispersal, we hypothesized that a motility mechanism may be
responsible for the dispersal activity.

This enhancement in motility was observed while

performing motility assays, where combined treatments of EIP + H2O2, both at micromolar
concentrations, resulted in increased swimming motility.

Future work should take these

observations into account when establishing a clearer mechanism of action of our treatments,
particularly against other well-known pathogens. Additionally, future work should focus on the
use of these compounds as possible adjuvants in combination with current antibiotic treatments.
Potentiating antibiotics, potentially reducing the effective doses of current treatments, would add
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yet another tool in the toolbox for combatting the impact of antibiotic resistance. Overall, the
application of EIP + H2O2 as an antibiofilm agent is quite promising.
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